Related Experiment Video

Updated: Apr 24, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis

Xiaoyin Niu1, Guangjie Chen1

  • 1Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, 280 South Chongqing Road, Shanghai 200025, China.

Journal of Immunology Research
|September 13, 2014
PubMed

Insights

Rheumatoid arthritis (RA) research focuses on identifying specific biomarkers for better patient management and treatment monitoring. This review discusses autoantibodies, novel biomarkers, and cytokines for RA diagnosis and prognosis.

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Biomarker Discovery

Background:

  • Rheumatoid arthritis (RA) is a prevalent autoimmune condition with unknown origins.
  • Current RA treatments manage inflammation and pain but have side effects and do not offer a cure.
  • There is a critical need for specific biomarkers to aid in RA diagnosis, prognosis, and disease monitoring.

Purpose of the Study:

  • To review current and emerging biomarkers for rheumatoid arthritis (RA).
  • To discuss the role of autoantibodies, novel biomarkers, and cytokines in RA management.
  • To highlight the importance of biomarkers for improving patient outcomes and clinical monitoring.

Main Methods:

  • Literature review of existing research on rheumatoid arthritis (RA) biomarkers.
  • Analysis of autoantibodies, novel biomarkers reflecting disease activity, and pathogenic cytokines.
  • Discussion of clinically used and investigational biomarkers for RA.

Main Results:

  • Autoantibodies are established tools for RA diagnosis and prognosis.
  • Novel biomarkers are emerging that correlate with clinical disease activity.
  • Pathogenic cytokines and newly identified biomarkers offer further insights into RA pathogenesis.

Conclusions:

  • Biomarker discovery is crucial for advancing rheumatoid arthritis (RA) treatment and patient care.
  • A comprehensive understanding of various biomarkers aids in personalized medicine approaches for RA.
  • Continued research into biomarkers promises improved diagnostic accuracy and therapeutic strategies for RA patients.

More Related Videos

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model11:03

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model

Published on: October 30, 2019

8.2K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

5.9K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
21
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
863